2017-01-09 10:51 ET - News Release
Mr. Phillippe Deschamps reports
HELIUS MEDICAL TECHNOLOGIES ANNOUNCES THAT ITS SHELF REGISTRATION FILED ON FORM S-3 WITH THE US SECURITIES AND EXCHANGE COMMISSION (SEC) HAS BEEN MADE EFFECTIVE
Helius Medical Technologies Inc. has filed a shelf registration statement on Form S-3 with the U.S. Securities and Exchange Commission, which has now been made effective. The registration statement allows Helius to issue various types of securities, including common stock, debt securities and/or warrants, up to an aggregate amount of $100-million (U.S.).
The company has no current plans to issue securities under the registration statement. Phillippe Deschamps, chief executive officer of Helius, added, "Having an effective shelf registration statement is aligned with our growth objectives and provides Helius with more flexible and cost-effective access to capital markets."
About Helius Medical Technologies
Helius Medical Technologies is a medical technology company focused on neurological wellness. Helius seeks to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself.
We seek Safe Harbor.
